Transforming Contraception and Oncofertility with AMH Insights – SSR
The Society for the Study of Reproduction (SSR) shared a post on LinkedIn:
“We are thrilled to announce the upcoming Roger V. Short Lecture featuring David Pépin at Harvard Medical School and 2025 Medal Recipient.
While reproductive innovation has remained largely unchanged for decades, Dr. Pépin’s lab is unlocking the power of Anti-Müllerian Hormone (AMH) to transform:
Contraception: Developing non-hormonal, long-term alternatives (including gene therapy in felines!).
Oncofertility: Protecting the ovarian reserve and uterine integrity during chemotherapy.
Aging: Understanding how ‘follicle pausing’ can improve long-term women’s health.
- When: Friday, March 6, 2026
- Time: 4:00 PM – 5:00 PM
- Where: Zoom
Don’t miss this deep dive into the translational pipeline of ovarian biology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 7, 2026, 18:14Masoud Zamani Esteki: The Key Knowledge Gaps in Modern Ovarian Biology
-
Aug 7, 2026, 18:01Jenny Gudge: New Opportunity for a Senior Fertility Nurse in Sussex
-
Aug 7, 2026, 17:37Clare Mansfield: I Don’t Think the Future of Fertility Care is Simply More Technology
-
Aug 7, 2026, 17:30Nevena Vidakovic: Reimagining the Future of Fertility at Merck
-
Aug 7, 2026, 17:04Understanding the Impact of Antisperm Antibodies on Fertility – Fertility Plus
-
Aug 7, 2026, 16:51Jess Bateson Invites Professionals to a Virtual PGT Education Programme
-
Aug 7, 2026, 16:08Diana Kayal: Some of the Things That Affect Fertility are Sitting in Your Kitchen Cupboard
-
Aug 7, 2026, 15:12Elizabeth Crammond: Improving Women’s Healthcare in Scotland – A Call for Safer, Integrated Care
-
Aug 7, 2026, 14:59Kalpesh Kapadia: A Man’s Semen Analysis May Be the Most Under-Ordered Health Test in India